AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 178 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,209,830 | -95.1% | 52,670 | -94.1% | 0.00% | -96.6% |
| Q4 2022 | $24,915,216 | +13.3% | 887,294 | +14.2% | 0.03% | +11.5% |
| Q3 2022 | $21,982,000 | +5368.2% | 777,296 | +6257.2% | 0.03% | – |
| Q4 2021 | $402,000 | -83.6% | 12,227 | -77.0% | 0.00% | -100.0% |
| Q3 2021 | $2,452,000 | +472.9% | 53,126 | +584.4% | 0.00% | – |
| Q2 2021 | $428,000 | -5.9% | 7,762 | -12.0% | 0.00% | – |
| Q1 2021 | $455,000 | +16.1% | 8,820 | -2.5% | 0.00% | – |
| Q4 2020 | $392,000 | +45.7% | 9,050 | +17.7% | 0.00% | – |
| Q3 2020 | $269,000 | -33.3% | 7,690 | +2.1% | 0.00% | -100.0% |
| Q2 2020 | $403,000 | -25.4% | 7,530 | -50.4% | 0.00% | – |
| Q1 2020 | $540,000 | +18.4% | 15,192 | +59.1% | 0.00% | -100.0% |
| Q4 2019 | $456,000 | +111.1% | 9,548 | +43.4% | 0.00% | – |
| Q3 2019 | $216,000 | -23.4% | 6,660 | -1.3% | 0.00% | -100.0% |
| Q4 2016 | $282,000 | – | 6,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |